What We're Reading: Page 258
Industry reads hand-picked by our editors
Nov 27, 2018
Nov 26, 2018
-
Reuters
U.S. benefits manager baulks after Novartis values gene therapy at $4-5 million
-
The New York Times
This City’s Overdose Deaths Have Plunged. Can Others Learn From It?
-
The Wall Street Journal
Pharma Stocks Soothe Stock-Market Malady
Nov 21, 2018
-
The New York Times
Will we ever cure Alzheimer's?
-
The Wall Street Journal
New ideas to fight the flu
-
Financial Times
Pharma companies put faith in AI for breakthroughs
-
The Washington Post
Everyone at high risk of HIV should be offered preventive meds, panel says
Nov 20, 2018
-
The Wall Street Journal
Novartis CEO Bets on Cutting-Edge Science to Remake Drug Giant
-
Forbes
Is Amarin's Fish-Oil-Derived Drug A Historic Breakthrough Or Not? It's Complicated
-
Reuters
Big pharma leaves big gaps: drugmakers urged to do more for poor
-
Axios
PhRMA spread money far and wide in Trump's first year
Nov 19, 2018
Nov 16, 2018
Nov 15, 2018
-
Reuters
Pfizer loses drug patent fight in UK top court, may face claims
-
The New York Times
U.S. companies are fighting their big pharma addiction
-
The Wall Street Journal
To curb wasteful health spending, Walmart to send employees traveling for spine surgery
Previous
